Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Ravn Jacobsen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Heart Journal|February 27, 2025
Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPTMia Ravn Jacobsen, Reza Jabbari, Erik Lerkevang Grove, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Impact of shifting from routine use of ticagrelor to prasugrel in myocardial infarction patients after PCI: a nationwide cohort studyMia Ravn Jacobsen, Peter Laursen Graversen, Reza Jabbari, et al.
International Journal of Cardiology|April 7, 2024
Familial clustering of unexplained heart failure - A Danish nationwide cohort studyCharlotte Glinge, Sara Rossetti, Louise Bruun Oestergaard, et al.
International Journal of Cardiology|July 26, 2021
Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarctionMia Ravn Jacobsen, Thomas Engstrøm, Christian Torp-Pedersen, et al.
Thrombosis and Haemostasis|September 18, 2024
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL SystemMiriam Euper, Jürgen Schreieck, Mareike Bladt, et al.
American Heart Journal|May 6, 2021
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarctionJasmine Melissa Madsen, Mia Ravn Jacobsen, Muhammad Sabbah, et al.
Journal of the American Heart Association|February 19, 2020
Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial InfarctionMia Ravn Jacobsen, Reza Jabbari, Charlotte Glinge, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 5, 2023
Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort studyMia Ravn Jacobsen, Reza Jabbari, Thomas Engstrøm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 15, 2022
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary interventionJasmine Melissa Madsen, Henning Kelbæk, Lars Nepper-Christensen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Heart Journal|February 27, 2025
Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPTMia Ravn Jacobsen, Reza Jabbari, Erik Lerkevang Grove, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2026
Impact of shifting from routine use of ticagrelor to prasugrel in myocardial infarction patients after PCI: a nationwide cohort studyMia Ravn Jacobsen, Peter Laursen Graversen, Reza Jabbari, et al.
International Journal of Cardiology|April 7, 2024
Familial clustering of unexplained heart failure - A Danish nationwide cohort studyCharlotte Glinge, Sara Rossetti, Louise Bruun Oestergaard, et al.
International Journal of Cardiology|July 26, 2021
Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarctionMia Ravn Jacobsen, Thomas Engstrøm, Christian Torp-Pedersen, et al.
Thrombosis and Haemostasis|September 18, 2024
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL SystemMiriam Euper, Jürgen Schreieck, Mareike Bladt, et al.
American Heart Journal|May 6, 2021
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarctionJasmine Melissa Madsen, Mia Ravn Jacobsen, Muhammad Sabbah, et al.
Journal of the American Heart Association|February 19, 2020
Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial InfarctionMia Ravn Jacobsen, Reza Jabbari, Charlotte Glinge, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 5, 2023
Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort studyMia Ravn Jacobsen, Reza Jabbari, Thomas Engstrøm, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 16, 2026
Transcatheter aortic valve thrombosisMia Ravn Jacobsen, Daniël C Overduin, Rikke Sørensen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 15, 2022
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary interventionJasmine Melissa Madsen, Henning Kelbæk, Lars Nepper-Christensen, et al.
Pageof 2